Adient (ADNT)

NYSEConsumer DiscretionaryAuto - PartsSnapshot 2026-10-23

$16.61-3.37%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Adient’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	3.73B
EPS	—	0.542
Annual ending 2027-09-30
Revenue	—	15.13B
EPS	—	2.889
Annual ending 2028-09-30
Revenue	—	15.44B
EPS	—	3.794

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Gross profit improvement to at least $257 million quarterly	Profit improved with gross profit rising to $257 million and operating income to $76 million.	Broken	Gross profit falls below $217 million next quarter	Gross profit: $235M FY2026-Q3; GAAP. Published target: >=257 million USD gross profit. Target period is not explicitly aligned with this observation. Source published Aug 5, 2026235,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 87282cea-007e-4ef5-81ee-3076ed7b1777. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Management maintains stable leadership and executes turnaround	A supporting condition in Adient's published investment case. The stated target is Stable management with no major disruptions.	Under Pressure	Significant management turnover or strategy reversal	CFO turnover (Mark Oswald departing, Peter Carlin hired) vs stable leadership target CFO Mark Oswald announced departure by Dec 2026; external hire Peter Carlin appointed. Q3 earnings missed estimates. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Operating income to reach at least $76 million quarterly	Profit improved with gross profit rising to $257 million and operating income to $76 million.	Broken	Operating income falls below $41 million next quarter	Operating income: $114M FY2026-Q3; GAAP. Published target: >=76 million USD operating income. Target period is not explicitly aligned with this observation. Source published Aug 5, 2026114,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q3. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue growth to sustain at least 1% annually	A primary condition in Adient's published investment case. The stated target is >=1% YoY revenue growth.	Broken	YoY revenue growth falls below 1% next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-09-30 · fmp

FY2028 EPS: comparable history unavailable.

FY2028 revenue$15.44B

$15.53B → $15.44B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-10-01	Unavailable	$15,534,631,984	3 / 9
2026-10-02	Unavailable	$15,534,631,984	3 / 9
2026-10-03	Unavailable	$15,534,631,984	3 / 9
2026-10-04	Unavailable	$15,534,631,984	3 / 9
2026-10-05	Unavailable	$15,534,631,984	3 / 9
2026-10-06	Unavailable	$15,534,631,984	3 / 9
2026-10-07	Unavailable	$15,534,631,984	3 / 9
2026-10-08	Unavailable	$15,531,122,964	3 / 9
2026-10-09	Unavailable	$15,531,122,964	3 / 9
2026-10-10	Unavailable	$15,531,122,964	3 / 9
2026-10-11	Unavailable	$15,531,122,964	3 / 9
2026-10-12	Unavailable	$15,531,122,964	3 / 9
2026-10-13	Unavailable	$15,531,122,964	3 / 9
2026-10-14	Unavailable	$15,531,122,964	3 / 9
2026-10-15	Unavailable	$15,531,122,964	3 / 9
2026-10-16	Unavailable	$15,531,122,964	3 / 9
2026-10-17	Unavailable	$15,531,122,964	3 / 9
2026-10-18	Unavailable	$15,531,122,964	3 / 9
2026-10-19	Unavailable	$15,531,122,964	3 / 9
2026-10-20	Unavailable	$15,483,122,964	3 / 9
2026-10-21	Unavailable	$15,483,122,964	3 / 9
2026-10-22	Unavailable	$15,483,122,964	3 / 9
2026-10-23	Unavailable	$15,444,256,297	3 / 9
2026-10-24	Unavailable	$15,444,256,297	3 / 9

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	7	5	1
2026-06-01	7	5	1
2026-07-01	8	5	1
2026-08-01	8	4	1
2026-09-01	9	4	1
2026-10-01	8	3	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 8 Buy / Strong Buy · 3 Hold · 1 Sell / Strong Sell

0 upgrades0 downgrades3 maintains

Recent actions · Sep 25–Oct 24 · 3 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Stifel NicolausOct 19 · prior May 7

$28.00 → $21.00-25.0%

BarclaysOct 9 · prior May 11

$29.00 → $22.00-24.1%

UBSOct 7 · prior Jul 9

$34.00 → $23.00-32.4%

$0$18.70$37.40

0 raises · 3 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Gross profit improvement to at least $257 million quarterlyPublished status: Broken
Management maintains stable leadership and executes turnaroundPublished status: Under Pressure
Operating income to reach at least $76 million quarterlyPublished status: Broken
Revenue growth to sustain at least 1% annuallyPublished status: Broken

Next proof point

Nov 4, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

2.0%Typical daily move · historical

Downside history

-38.7%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Adient outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a cyclical auto-supplier business with a growth-and-margin improvement thesis, rather than a proven durable compounder. The signal has shifted from mixed to mildly favorable, while recent performance remains below its industry cohort and the thesis is still in a watch state.

What's priced into Adient

The valuation evidence is mixed: ADNT screens cheap versus peers, while another peer comparison measure shows a 0.7 premium. The expectations gap is negative, which suggests assumptions are not especially demanding, and the priced-in fragility assessment is low with no warning gates triggered.

What the fundamentals likely do

Near term, revenue growth has been consistent with management’s priority, including higher consolidated revenue from Q1 to Q3 and strong China sales against a declining market. Margin progress is mixed: Q3 gross profit fell from Q2, adjusted EBITDA margin was slightly lower year over year, and net income declined; recent performance also trails the industry cohort. Management is on track with growth and capital allocation priorities, but margin pressure, erratic earnings surprises, and a possible guidance cut remain risks.

What Adient hinges on

Over the next few quarters, the thesis depends on whether revenue growth can translate into stronger gross profit and operating income. A guidance cut would be a meaningful negative, while continued earnings strength and higher guidance from sector bellwethers GPC, BWA, and APTV could support the sector backdrop; misses or lower guidance from those companies could weaken it.